Your browser doesn't support javascript.
loading
Virology-the path forward.
Rasmussen, Angela L; Gronvall, Gigi K; Lowen, Anice C; Goodrum, Felicia; Alwine, James; Andersen, Kristian G; Anthony, Simon J; Baines, Joel; Banerjee, Arinjay; Broadbent, Andrew J; Brooke, Christopher B; Campos, Samuel K; Caposio, Patrizia; Casadevall, Arturo; Chan, Gary C; Cliffe, Anna R; Collins-McMillen, Donna; Connell, Nancy; Damania, Blossom; Daugherty, Matthew D; Debbink, Kari; Dermody, Terence S; DiMaio, Daniel; Duprex, W Paul; Emerman, Michael; Galloway, Denise A; Garry, Robert F; Goldstein, Stephen A; Greninger, Alexander L; Hartman, Amy L; Hogue, Brenda G; Horner, Stacy M; Hotez, Peter J; Jung, Jae U; Kamil, Jeremy P; Karst, Stephanie M; Laimins, Lou; Lakdawala, Seema S; Landais, Igor; Letko, Michael; Lindenbach, Brett; Liu, Shan-Lu; Luftig, Micah; McFadden, Grant; Mehle, Andrew; Morrison, Juliet; Moscona, Anne; Mühlberger, Elke; Munger, Joshua; Münger, Karl.
Afiliação
  • Rasmussen AL; Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.
  • Gronvall GK; Department of Biochemistry, Microbiology, and Immunology, University of Saskatchewan, Saskatoon, Canada.
  • Lowen AC; Department of Ecology and Evolution, Stony Brook University, Stony Brook, New York, USA.
  • Goodrum F; Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Alwine J; Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
  • Andersen KG; Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
  • Anthony SJ; Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Baines J; Department of Immunology and Microbiology, Scripps Research, La Jolla, California, USA.
  • Banerjee A; Department of Pathology, Microbiology, and Immunology, University of California, Davis, Davis, California, USA.
  • Broadbent AJ; Department of Microbiology and Immunology, Cornell University, Ithaca, New York, USA.
  • Brooke CB; Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Canada.
  • Campos SK; Department of Animal and Avian Sciences, University of Maryland, College Park, Maryland, USA.
  • Caposio P; Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
  • Casadevall A; Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
  • Chan GC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
  • Cliffe AR; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Collins-McMillen D; Department of Microbiology and Immunology, SUNY Upstate Medical Center, Syracuse, New York, USA.
  • Connell N; Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia, USA.
  • Damania B; Department of Immunobiology, University of Arizona, Tucson, Arizona, USA.
  • Daugherty MD; Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Debbink K; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Dermody TS; Department of Molecular Biology, University of California, San Diego, La Jolla, California, USA.
  • DiMaio D; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Duprex WP; Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Emerman M; Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.
  • Galloway DA; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Garry RF; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Goldstein SA; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Greninger AL; Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Hartman AL; Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
  • Hogue BG; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Horner SM; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Hotez PJ; Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.
  • Jung JU; School of Life Sciences, Arizona State University, Tempe, Arizona, USA.
  • Kamil JP; Department of Integrative Immunobiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Karst SM; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Laimins L; Department of Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Lakdawala SS; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Landais I; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
  • Letko M; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, Florida, USA.
  • Lindenbach B; Department of Microbiology, Ohio State University, Wooster, Ohio, USA.
  • Liu S-L; Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA.
  • Luftig M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, USA.
  • McFadden G; Paul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA.
  • Mehle A; Department of Microbial Pathogenesis, Yale University, New Haven, USA.
  • Morrison J; Department of Microbiology, Ohio State University, Wooster, Ohio, USA.
  • Moscona A; Viruses and Emerging Pathogens Program, Infectious Diseases Institute, Ohio State University, Wooster, Ohio, USA.
  • Mühlberger E; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.
  • Munger J; School of Life Sciences, Arizona State University, Tempe, Arizona, USA.
  • Münger K; Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, USA.
J Virol ; 98(1): e0179123, 2024 Jan 23.
Article em En | MEDLINE | ID: mdl-38168672
ABSTRACT
In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Virologia / Contenção de Riscos Biológicos / Pesquisa Biomédica Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Virol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Virologia / Contenção de Riscos Biológicos / Pesquisa Biomédica Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Virol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá